ADVFN - Advanced Financial Network.
HOME» NASDAQ » M » MYL Stock Price » MYL Stock News

Mylan Inc. Share News

 Mylan Inc. (mm) Stock Price
MYL Stock Price
 Mylan Inc. (mm) Stock Chart
MYL Stock Chart
 Mylan Inc. (mm) Stock News
MYL Stock News
 Mylan Inc. (mm) Company Information
MYL Company Information
 Mylan Inc. (mm) Stock Trades
MYL Stock Trades

US Judge Upholds Validity Of Merck's Vytorin Patent

By Peter Loftus Of DOW JONES NEWSWIRES A federal judge has upheld the validity of a U.S. patent covering Merck & Co.'s (MRK) Vytorin cholesterol-lowering drug, which could stave off competing generic copies for several years. In an opinion released Friday, U.S. District Judge Jose Linares in federal court in Newark, N.J., said a patent for Vytorin was valid and enforceable. Merck, based in Whitehouse Station, N.J., said in a recent regulatory filing it expects its U.S. exclusivity for Vytorin and a related drug, Zetia, to expire in April 2017. Mylan Inc. (MYL) had applied for U.S. Food and Drug Administration approval to sell a generic version of Vytorin before its patent protection expired, arguing that the patent was invalid and unenforceable. Schering-Plough, which was acquired by Merck in 2009, filed a patent-infringement lawsuit against Mylan in late 2009, seeking to block Mylan's product. A trial was held in December 2011, leading to Judge Linares's opinion Friday. On a conference call with analysts Friday morning, Merck Chief Executive Kenneth Frazier said he was anticipating a favorable decision. "We believe this is a patent that is valid and enforceable," he said. A Mylan spokeswoman couldn't immediately be reached. Earlier Friday, Merck reported first-quarter Vytorin sales of $444 million and Zetia sales of $614 million. Merck previously reached a settlement of patent litigation for Zetia with generics manufacturer Glenmark Pharmaceuticals. The pact will allow Glenmark to sell generic Zetia in December 2016, subject to final regulatory approval. -By Peter Loftus, Dow Jones Newswires; +1-215-982-5581; peter.loftus@dowjones.com

Stock News for Mylan Inc. (MYL)
DateTimeHeadline
03/30/201510:19:38The Best Stocks To Buy This Week
03/30/201508:38:10Abbott Labs Files to Sell Nearly a Third of Its Mylan Stake
03/30/201506:30:00Mylan N.V. Announces Commencement of Secondary Public Offering...
03/26/201508:36:34Mylan Is One Of The Most Undervalued Generic Companies
03/26/201503:20:53Top Large Cap Stocks That Investors Can Buy Now
03/12/201512:30:00Mylan N.V. and Mylan Inc. Announce Successful Completion of Consent...
03/11/201507:30:00Mylan Launches Generic Subutex® Sublingual Tablets
03/11/201507:00:00Mylan Launches Generic Antabuse® Tablets
03/11/201506:30:00Mylan Launches First and Only Available Intermediate Dosage Strengths...
03/10/201508:52:06Mylan Posts Lowest Full-Year Comprehensive Earnings Since 2008
03/09/201505:48:27The Top Scoring Stocks To Buy This Week
03/06/201508:00:00Mylan to Present at the Barclays Global Healthcare Conference
03/03/201518:18:10MARKET SNAPSHOT: U.S. Stocks Retreat From Records; Car Sales...
03/03/201518:08:36MARKET SNAPSHOT: U.S. Stocks Retreat From Records; Car Sales...
03/03/201518:00:56MARKET SNAPSHOT: U.S. Stocks Retreat From Records After Netanyahu...
03/03/201517:58:40MARKET SNAPSHOT: U.S. Stocks Retreat From Records After Netanyahu...
03/03/201517:49:27MARKET SNAPSHOT: U.S. Stock Slip A Day After Nasdaq Tops 5,000
03/03/201517:35:07MARKET SNAPSHOT: U.S. Stock Futures Signal Lower Open A Day After...
03/03/201508:55:00Mylan N.V. and Mylan Inc. Announce Commencement of Consent Solicitations...
03/03/201508:36:07MARKET SNAPSHOT: U.S. Stocks: Futures Retreat After Nasdaq Breaks...

Mylan Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad